Heartfelt with Dr Melissa Walton-Shirley

View all posts »

Atrial fibrillation, heart rate control, remote monitoring of ICDs, update on stents, betrixaban, antiplatelet therapies, more on clopidogrel

Mar 15, 2010 19:55 EDT


From ACC 2010, Dr Melissa Walton-Shirley reviews today's late-breaking trials including STOP-AF, CABANA, RACE-2, CONNECT, SORT OUT III, ISAR-TEST-2, REAL-LATE, and ZEST-LATE.

See:

STOP-AF and CABANA: Trials show effectiveness of ablation over drugs in AF

"Lenient" as good as "strict" ventricular rate control in permanent AF: RACE-2 trial

Faster CONNECTions: Remote monitoring reduces event-to-decision time

New factor Xa inhibitor betrixaban safe in phase 2 AF trial

SORT OUT III: Cypher bests Endeavor at 18 months

Polymer-free, dual-drug DES shows little late catch-up in ISAR-TEST-2

Optimal dual antiplatelet duration in REAL-LATE, ZEST-LATE: Too little, too soon

 



« Previous Post
Gamblers Anonymous: Help for those who make blanket statements on clopidogrel duration following DES
Mar 16, 2010 08:51 EDT Next post »
EVEREST II mitral-valve clip: It's a good start but still a long way to the top
Mar 15, 2010 11:30 EDT



Your comments
Atrial fibrillation, heart rate control, remote monitoring of ICDs, update on stents, betrixaban, antiplatelet therapies, more on clopidogrel
# 1 of 1
March 16, 2010 11:13 (EDT)
Melissa
Just wanted to add that in the STOP-AF trial, either I left off the statement from my piece or we edited it.....but the most salient point was that sinus rhythm was maintained at 1 year in 70% of the ablation patients vs. ONLY 7% of the medication only patients.  I'm very aggressive with referral for afib ablation and I wanted to make that point and appreciate all of our wonderful albators for moving this technology forward!!!!

You must be a member (with full membership) to post a comment.
Already a member?
Enter your login information below:
 Remember me on this computer
Forgot your username and/or password?
        Login        
Enjoy all the benefits of theheart.org

With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.

Membership is free!

    Join now for full access    
About Dr Melissa Walton-Shirley
Dr Walton-Shirley performs invasive cardiology, nuclear cardiology, and stress echocardiography in a private practice in Glasgow, KY.

Her chief medical interests are CHF/hypertrophic obstructive cardiomyopathy and the promotion of primary PCI for acute MI. Recently she played a significant role in helping to launch an ambitious pilot study of primary PCI in Kentucky, the Kentucky Primary Angioplasty Pilot Project. She has also participated in the TIMI 19, Duke-HF, NRMI, and CRUSADE trials and is proud to have been an advocate of the first smoke-free initiative in Kentucky (2011). She champions a smoke-free America.

Dr Walton-Shirley received her undergraduate degree at the University of Kentucky and went to medical school and did her residency and fellowship at the University of Louisville. She is married with two daughters. Her interests include singing, writing poetry and songs, fitness, and, of course, theheart.org.